SHIFT Newsroom · GLOBAL
Female mice retained muscle mass in a short semaglutide experiment
A study in Diabetes used leptin-deficient ob/ob mice to examine sex differences during three weeks of semaglutide treatment.
A study in Diabetes used leptin-deficient ob/ob mice to examine sex differences during three weeks of semaglutide treatment. Female mice retained muscle mass in this experiment, while male mice had relatively small losses; muscle force was maintained in both groups. These findings concern this mouse model. They do not show that women are protected from muscle loss during treatment.
SHIFT’s take
Read the study design and limits alongside the finding. This article does not determine individual treatment suitability.